EMPLOYEE SHARE OPTION SCHEME (CONT’D) The option prices and the details in the movement of the options granted are as follows:- Number of Options over Ordinary Shares Grant Date Exercise Price Remaining Contractual Life of Options At 1.1.2025 Granted Exercised At 31.12.2025 2025 22 April 2024 RM0.90 3.33 Years 23,472,100 - (4,729,800) 18,742,300 For options exercised during the financial year, the weighted average share price at the date of exercise was RM1.79. The remaining number of options vested and exercisable as at 31 December 2025 was 2,183,300 and have an exercise price of RM0.90 and a weighted average remaining contractual life of 3.33 years. BAD AND DOUBTFUL DEBTS Before the financial statements of the Group and of the Company were made out, the directors took reasonable steps to ascertain that action had been taken in relation to the writing off of bad debts and the making of allowance for impairment losses on receivables and satisfied themselves that there are no known bad debts and that no allowance for impairment losses on receivables is required. At the date of this report, the directors are not aware of any circumstances that would require the writing off of bad debts, or the allowance for impairment losses on receivables in the financial statements of the Group and of the Company. CURRENT ASSETS Before the financial statements of the Group and of the Company were made out, the directors took reasonable steps to ensure that any current assets, which were unlikely to be realised in the ordinary course of business, including their value as shown in the accounting records of the Group and of the Company, have been written down to an amount which they might be expected so to realise. At the date of this report, the directors are not aware of any circumstances which would render the values attributed to the current assets in the financial statements misleading. VALUATION METHODS At the date of this report, the directors are not aware of any circumstances which have arisen which render adherence to the existing methods of valuation of assets or liabilities of the Group and of the Company misleading or inappropriate. 143 Annual Report 2025
RkJQdWJsaXNoZXIy NDgzMzc=